Search

Search Constraints

You searched for: Author/Creator Snowden, Stuart G.

Search Results

1. [F1–02–02]: DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER'S DISEASE PATHOLOGY AND PROGRESSION. (1st July 2017)

2. [P1–289]: DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN (CSF Aβ OR AMYLOID‐PET) IN THE EMIF‐AD BIOMARKER DISCOVERY COHORT. (1st July 2017)

3. [P3–166]: NEUROTRANSMITTER‐SPECIFIC METABOLISM IS RELATED TO SEVERITY OF PATHOLOGY AND SYMPTOM EXPRESSION IN ALZHEIMER's DISEASE. (1st July 2017)

4. Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross-Sectional Study. Issue 6 (19th June 2022)

6. F1‐02‐02: DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN AND ALZHEIMER'S DISEASE PROGRESSION. (1st July 2006)

7. Metabolomics in early life and the association with body composition at age 2 years. Issue 3 (13th October 2021)

8. P3‐233: PLASMA PRIMARY FATTY AMIDES ASSOCIATE TO CSF AMYLOID LEVELS AND ALZHEIMER'S DISEASE PROGRESSION IN THE EMIF‐AD BIOMARKER DISCOVERY COHORT. (1st July 2006)

9. Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17‐beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms. Issue 8 (11th April 2022)